Replek AD (XMAE:REPL) ROCE % : 33.20% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Replek AD ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Replek AD's annualized ROCE % for the quarter that ended in Dec. 2024 was 33.20%.

Replek AD ROCE % Historical Data

The historical data trend for Replek AD's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Replek AD ROCE % Chart

Replek AD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

11.85

9.50

6.12

15.63

11.50

Replek AD Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-2.93	41.14	-	-3.57	33.20

Replek AD ROCE % Calculation

Replek AD's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	279.765	/	( ( (2918.352 - 605.13)	+	(3308.062 - 756.506) )	/ 2 )
	=	279.765	/	( (2313.222	+	2551.556)	/ 2 )
	=	279.765	/	2432.389
	=	11.50 %

Replek AD's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	847.236	/	( ( (0 - 0)	+	(3308.062 - 756.506) )	/ 1 )
	=	847.236	/	( ( 0	+	2551.556 )	/ 1 )
	=	847.236	/	2551.556
	=	33.20 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Replek AD (XMAE:REPL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Replek AD ROCE % Related Terms

Thank you for viewing the detailed overview of Replek AD's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Replek AD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kozle 188, Skopje, MKD

Website

https://www.replek.mk

Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.